Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks' Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies

Main Article Content

A Blauvelt
B Strober
R Langley
D Burge
L Pisenti
M Yassine
S Kavanagh
C Arendt
R Rolleri
K Reich


certolizumab, psoriasis, clinical trial


Abstract not available.


Disclosures: Study sponsored by UCB Pharma.


Copyright 2018 SKIN

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 > >>